Max Healthcare Institute (NSE:MAXHEALTH) ROCE %: 13.49% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAXHEALTH Max Healthcare Institute Ltd NSE:MAXHEALTH
93 GF Score
Price ₹1,000.00
GF Value ₹1,432.61
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Max Healthcare Institute ROCE %?

Max Healthcare Institute NSE:MAXHEALTH +0.21% 93 ROCE % is 13.49% as of Jun. 2026. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 93/100 and a GF Value™ of ₹1,432.61 (Significantly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Max Healthcare Institute's annualized ROCE % for the quarter that ended in Jun. 2026 was 13.49%.

Max Healthcare Institute  (NSE:MAXHEALTH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Max Healthcare Institute ROCE % Related Terms

Max Healthcare Institute ROCE % Historical Data

* Premium members only.

The historical data trend for Max Healthcare Institute's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Max Healthcare Institute ROCE % Chart

Max Healthcare Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.23 12.98 14.24 12.87 13.29

Max Healthcare Institute Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.58 14.12 11.98 14.12 13.49
NSE:MAXHEALTH
93GF Score
Max Healthcare Institute Ltd NSE:MAXHEALTH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Max Healthcare Institute ROCE % Calculation

Max Healthcare Institute's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=18906.2/( ( (152144.8 - 18061.7) + (172309.4 - 21869.4) )/ 2 )
=18906.2/( (134083.1+150440)/ 2 )
=18906.2/142261.55
=13.29 %

Max Healthcare Institute's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=20292.4/( ( (172309.4 - 21869.4) + (0 - 0) )/ 1 )
=20292.4/( ( 150440 + 0 )/ 1 )
=20292.4/150440
=13.49 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.49% mean?
Max Healthcare Institute (NSE:MAXHEALTH) has a ROCE % of 13.49% as of Jun. 2026.
Is Max Healthcare Institute's ROCE % too high?
Max Healthcare Institute's current ROCE % is 13.49%. The Healthcare Providers & Services industry median ROCE % is 6.63. Max Healthcare Institute's value of 13.49% is 103.5% above this industry median. Overall, Max Healthcare Institute has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's ROCE % compare to HCA and THC?
Max Healthcare Institute's ROCE % of 13.49% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.63. Max Healthcare Institute's value of 13.49% is 103.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.63, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current ROCE % of 13.49% is 103.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current ROCE % is 13.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,432.61, compared to a current price of ₹1,000.00 — trading 30.2% below its estimated fair value. The current ROCE % is 13.49% and 103.5% above the Healthcare Providers & Services industry median of 6.63. Max Healthcare Institute's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current ROCE % is 13.49% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?

Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued. The current stock price of ₹1,000.00 is trading 30.2% below its estimated GF Value™ of ₹1,432.61. GuruFocus considers Max Healthcare Institute to be Significantly Undervalued.

Key valuation signals for NSE:MAXHEALTH:

  • ROCE %: 13.49%
  • GF Value™: ₹1,432.61 vs. price of ₹1,000.00 (30.2% below fair value)
  • GF Score™: 93/100 with 1 warning sign
  • Industry Position: 103.5% above the Healthcare Providers & Services median

No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Max Healthcare Institute Business Description

Other Exchanges 543220:India
Address Capital Cyberscape, Sector-59, 2nd Floor, Gurugram, HR, IND, 122 102
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
93GF Score

Get the complete analysis for NSE:MAXHEALTH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,000.00
Price
₹1,432.61
GF Value